Pfizer
Highlights:
Financial Strength A++
Price Stability 90
Earnings Predictability 100
Safety 1 (highest)
3-5 yr. projections: $45 - $55.
My (elementary) analysis:
This stock was grossly overpriced from 1997-2000 and has overcorrected.
Now selling at close to book value, at a PE of 13, it is a very good value.
The company has been aggressively buying it's own stock.
Although it has suffered through problems in the last couple years, it is still financially strong, has a solid ROE, and
is poised for strong price gains when any good news comes down the pipe.
Buy it up.
(in order not to hijack James' thread, I put Pfizer in its' own thread. )
I think James' idea is a very good one.